recombinant rat il 1β Search Results


91
Gold Biotechnology Inc il 1β
Parental MDA-PCa-2b (MDA2b) and chronic IL-1 subline cells (MDA-αs1, MDA-αs2, MDA-βs1, MDA-βs2) were treated acutely for 3 days (A, C) or 6 days (B) with vehicle control (V), 25 ng/ml IL-1α (a), or 25 <t>ng/ml</t> <t>IL-1β</t> (b) and analyzed for cell viability using MTT (A, B) or protein accumulation by western blot (C). Acute IL-1 exposure reduces cell viability and proliferation, reduces full-length PARP (indicative of cell death activation), induces SOD2 and LCN2 protein accumulation (canonical IL-1-induced genes), and reduces AR and NKX3.1 (canonical AR target gene) protein accumulation in MDA-PCa-2b parental cells, but has little to no effect on the chronic IL-1 sublines. Thus, the IL-1 sublines evolved insensitivity to IL-1. Error bars, ± STDEV of 4 biological replicates; p-value, *≤ 0.05, **≤ 0.005, ***≤ 0.005, NS = not significant. Fold MTT optical density (OD) is normalized to treatment control. β-actin is the western blot loading control.
Il 1β, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il 1β/product/Gold Biotechnology Inc
Average 91 stars, based on 1 article reviews
il 1β - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier

95
Bio-Techne corporation recombinant rat il-1 beta/il-1f2 protein
Parental MDA-PCa-2b (MDA2b) and chronic IL-1 subline cells (MDA-αs1, MDA-αs2, MDA-βs1, MDA-βs2) were treated acutely for 3 days (A, C) or 6 days (B) with vehicle control (V), 25 ng/ml IL-1α (a), or 25 <t>ng/ml</t> <t>IL-1β</t> (b) and analyzed for cell viability using MTT (A, B) or protein accumulation by western blot (C). Acute IL-1 exposure reduces cell viability and proliferation, reduces full-length PARP (indicative of cell death activation), induces SOD2 and LCN2 protein accumulation (canonical IL-1-induced genes), and reduces AR and NKX3.1 (canonical AR target gene) protein accumulation in MDA-PCa-2b parental cells, but has little to no effect on the chronic IL-1 sublines. Thus, the IL-1 sublines evolved insensitivity to IL-1. Error bars, ± STDEV of 4 biological replicates; p-value, *≤ 0.05, **≤ 0.005, ***≤ 0.005, NS = not significant. Fold MTT optical density (OD) is normalized to treatment control. β-actin is the western blot loading control.
Recombinant Rat Il 1 Beta/Il 1f2 Protein, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant rat il-1 beta/il-1f2 protein/product/Bio-Techne corporation
Average 95 stars, based on 1 article reviews
recombinant rat il-1 beta/il-1f2 protein - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

90
ICN Pharmaceuticals rat recombinant interleukin 1β (il-1β)
Experimental protocols illustrating the times and routes of antiserum and drug adminstration. i.c.v.=intracerebroventicularly; i.p.=intraperitoneally; s.c. subcutaneously. pAb=anti-annexin <t>1</t> polyclonal antiserum (3 μl rat−1 i.c.v. or 1 ml kg−1, s.c); NSS=non-immune sheep serum (3 μl rat−1, i.c.v. or 1 ml kg−1, s.c); Cort=corticosterone (500 μg kg−1, i.p. in a volume of 1 ml kg−1); <t>IL-1β=interleukin</t> 1β (10 ng rat−1 in a volume of 3 μl, i.c.v. or 500 μg kg−1, i.p. in a volume of 1 ml kg−1); ANX-1=annexin 1Ac2 – 26 (0.1 – 10 ng rat−1 in a volume of 3 μl, i.c.v.). Corresponding volumes of saline (Sal) or vehicle (Veh) were administered as controls where appropriate.
Rat Recombinant Interleukin 1β (Il 1β), supplied by ICN Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rat recombinant interleukin 1β (il-1β)/product/ICN Pharmaceuticals
Average 90 stars, based on 1 article reviews
rat recombinant interleukin 1β (il-1β) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
AbMole Bioscience recombinant rat il-1β
Experimental protocols illustrating the times and routes of antiserum and drug adminstration. i.c.v.=intracerebroventicularly; i.p.=intraperitoneally; s.c. subcutaneously. pAb=anti-annexin <t>1</t> polyclonal antiserum (3 μl rat−1 i.c.v. or 1 ml kg−1, s.c); NSS=non-immune sheep serum (3 μl rat−1, i.c.v. or 1 ml kg−1, s.c); Cort=corticosterone (500 μg kg−1, i.p. in a volume of 1 ml kg−1); <t>IL-1β=interleukin</t> 1β (10 ng rat−1 in a volume of 3 μl, i.c.v. or 500 μg kg−1, i.p. in a volume of 1 ml kg−1); ANX-1=annexin 1Ac2 – 26 (0.1 – 10 ng rat−1 in a volume of 3 μl, i.c.v.). Corresponding volumes of saline (Sal) or vehicle (Veh) were administered as controls where appropriate.
Recombinant Rat Il 1β, supplied by AbMole Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant rat il-1β/product/AbMole Bioscience
Average 90 stars, based on 1 article reviews
recombinant rat il-1β - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Parental MDA-PCa-2b (MDA2b) and chronic IL-1 subline cells (MDA-αs1, MDA-αs2, MDA-βs1, MDA-βs2) were treated acutely for 3 days (A, C) or 6 days (B) with vehicle control (V), 25 ng/ml IL-1α (a), or 25 ng/ml IL-1β (b) and analyzed for cell viability using MTT (A, B) or protein accumulation by western blot (C). Acute IL-1 exposure reduces cell viability and proliferation, reduces full-length PARP (indicative of cell death activation), induces SOD2 and LCN2 protein accumulation (canonical IL-1-induced genes), and reduces AR and NKX3.1 (canonical AR target gene) protein accumulation in MDA-PCa-2b parental cells, but has little to no effect on the chronic IL-1 sublines. Thus, the IL-1 sublines evolved insensitivity to IL-1. Error bars, ± STDEV of 4 biological replicates; p-value, *≤ 0.05, **≤ 0.005, ***≤ 0.005, NS = not significant. Fold MTT optical density (OD) is normalized to treatment control. β-actin is the western blot loading control.

Journal: Journal of cellular signaling

Article Title: Chronic IL-1 Exposed AR + PCa Cell Lines Show Conserved Loss of IL-1 Sensitivity and Evolve Both Conserved and Unique Differential Gene Expression Profiles

doi:

Figure Lengend Snippet: Parental MDA-PCa-2b (MDA2b) and chronic IL-1 subline cells (MDA-αs1, MDA-αs2, MDA-βs1, MDA-βs2) were treated acutely for 3 days (A, C) or 6 days (B) with vehicle control (V), 25 ng/ml IL-1α (a), or 25 ng/ml IL-1β (b) and analyzed for cell viability using MTT (A, B) or protein accumulation by western blot (C). Acute IL-1 exposure reduces cell viability and proliferation, reduces full-length PARP (indicative of cell death activation), induces SOD2 and LCN2 protein accumulation (canonical IL-1-induced genes), and reduces AR and NKX3.1 (canonical AR target gene) protein accumulation in MDA-PCa-2b parental cells, but has little to no effect on the chronic IL-1 sublines. Thus, the IL-1 sublines evolved insensitivity to IL-1. Error bars, ± STDEV of 4 biological replicates; p-value, *≤ 0.05, **≤ 0.005, ***≤ 0.005, NS = not significant. Fold MTT optical density (OD) is normalized to treatment control. β-actin is the western blot loading control.

Article Snippet: MDA-PCa-2b cells were maintained in HPC1/20% FB Essence (FBE) containing 0.5 ng/ml IL-1α (Gold Bio, St. Louis, MO; 1110–01A-10) or IL-1β (Gold Bio, St. Louis, MO; 1110–01B-10) for approximately 4 months; and the proliferative colonies that emerged were expanded and termed MDA-PCa-2b IL-1α subline (MDA-αs) and MDA-PCa-2b IL-1β subline (MDA-βs).

Techniques: Western Blot, Activation Assay

(A) MDA-PCA-2b parental (MDA2b) and chronic IL-1 subline (MDA-αs1, MDA-αs2, MDA-βs1, MDA-βs2) cells were treated acutely for 3 days with vehicle control, 25 ng/ml IL-1α, or 25 ng/ml IL-1β and analyzed by RT-qPCR for mRNA levels of the IL-1 receptor, IL-1R1 . Acute IL-1 exposure does not increase IL-1 receptor ( IL-1R1 ) mRNA levels in parental cells, suggesting basal IL-1R1 levels are sufficient to mediate IL-1 signaling. Furthermore, IL-1 does not show a differential effect on IL-1R1 mRNA levels in parental versus subline cells, suggesting subline insensitivity is independent of IL-1R1 levels. (B) Vehicle control treated cells were compared for basal mRNA levels of IL-1R1 and of canonical IL-1-induced genes, LCN2 , NOX1 , and SOD2 . IL-1R1, LCN2 , NOX1 , and SOD2 basal mRNA levels are comparable across the parental and subline cells, suggesting chronic IL-1 exposure does not induce constitutive activation of canonical IL-1 intracellular signaling. These data suggest that MDA-PCa-2b cell lines evolve insensitivity to exogenous chronic IL-1 exposure independent of IL-1R1 levels or constitutive activation of intracellular IL-1 signaling. Error bars, ± STDEV of 3 biological replicates; p-value, *≤ 0.05, **≤ 0.005, ***≤ 0.005, NS = not significant. For IL-1-treated cells, mRNA levels are normalized to vehicle control for each cell line. For basal expression, mRNA levels are normalized to the parental cell line.

Journal: Journal of cellular signaling

Article Title: Chronic IL-1 Exposed AR + PCa Cell Lines Show Conserved Loss of IL-1 Sensitivity and Evolve Both Conserved and Unique Differential Gene Expression Profiles

doi:

Figure Lengend Snippet: (A) MDA-PCA-2b parental (MDA2b) and chronic IL-1 subline (MDA-αs1, MDA-αs2, MDA-βs1, MDA-βs2) cells were treated acutely for 3 days with vehicle control, 25 ng/ml IL-1α, or 25 ng/ml IL-1β and analyzed by RT-qPCR for mRNA levels of the IL-1 receptor, IL-1R1 . Acute IL-1 exposure does not increase IL-1 receptor ( IL-1R1 ) mRNA levels in parental cells, suggesting basal IL-1R1 levels are sufficient to mediate IL-1 signaling. Furthermore, IL-1 does not show a differential effect on IL-1R1 mRNA levels in parental versus subline cells, suggesting subline insensitivity is independent of IL-1R1 levels. (B) Vehicle control treated cells were compared for basal mRNA levels of IL-1R1 and of canonical IL-1-induced genes, LCN2 , NOX1 , and SOD2 . IL-1R1, LCN2 , NOX1 , and SOD2 basal mRNA levels are comparable across the parental and subline cells, suggesting chronic IL-1 exposure does not induce constitutive activation of canonical IL-1 intracellular signaling. These data suggest that MDA-PCa-2b cell lines evolve insensitivity to exogenous chronic IL-1 exposure independent of IL-1R1 levels or constitutive activation of intracellular IL-1 signaling. Error bars, ± STDEV of 3 biological replicates; p-value, *≤ 0.05, **≤ 0.005, ***≤ 0.005, NS = not significant. For IL-1-treated cells, mRNA levels are normalized to vehicle control for each cell line. For basal expression, mRNA levels are normalized to the parental cell line.

Article Snippet: MDA-PCa-2b cells were maintained in HPC1/20% FB Essence (FBE) containing 0.5 ng/ml IL-1α (Gold Bio, St. Louis, MO; 1110–01A-10) or IL-1β (Gold Bio, St. Louis, MO; 1110–01B-10) for approximately 4 months; and the proliferative colonies that emerged were expanded and termed MDA-PCa-2b IL-1α subline (MDA-αs) and MDA-PCa-2b IL-1β subline (MDA-βs).

Techniques: Quantitative RT-PCR, Activation Assay, Expressing

Parental (MDA-PCA-2b (MDA2b), LNCaP) and subline (MDA-αs1, MDA-αs2, MDA-βs1, MDA-βs2, LNas1, LNbs1) cells were treated acutely for 3 days with vehicle control, 25 ng/ml IL-1α, or 25 ng/ml IL-1β and analyzed by RT-qPCR for mRNA levels (A, B, C). Acute IL-1 exposure increases LCN2 , NOX1 , and SOD2 mRNA levels in parental MDA-PCa-2b and LNCaP cells, but acute IL-1 exposure has attenuated or no effect on mRNA levels in the subline cells. Thus, both LNCaP and MDA-PCa-2b cell lines show conserved intracellular response to acute IL-1-induced changes mRNA levels and evolve chronic IL-1 insensitivity independent of constitutive canonical IL-1 intracellular signaling. Error bars, ± STDEV of 3 biological replicates; p-value, *≤ 0.05, **≤ 0.005, ***≤ 0.005, NS = not significant. For IL-1-treated cells, mRNA levels are normalized to vehicle control for each cell line.

Journal: Journal of cellular signaling

Article Title: Chronic IL-1 Exposed AR + PCa Cell Lines Show Conserved Loss of IL-1 Sensitivity and Evolve Both Conserved and Unique Differential Gene Expression Profiles

doi:

Figure Lengend Snippet: Parental (MDA-PCA-2b (MDA2b), LNCaP) and subline (MDA-αs1, MDA-αs2, MDA-βs1, MDA-βs2, LNas1, LNbs1) cells were treated acutely for 3 days with vehicle control, 25 ng/ml IL-1α, or 25 ng/ml IL-1β and analyzed by RT-qPCR for mRNA levels (A, B, C). Acute IL-1 exposure increases LCN2 , NOX1 , and SOD2 mRNA levels in parental MDA-PCa-2b and LNCaP cells, but acute IL-1 exposure has attenuated or no effect on mRNA levels in the subline cells. Thus, both LNCaP and MDA-PCa-2b cell lines show conserved intracellular response to acute IL-1-induced changes mRNA levels and evolve chronic IL-1 insensitivity independent of constitutive canonical IL-1 intracellular signaling. Error bars, ± STDEV of 3 biological replicates; p-value, *≤ 0.05, **≤ 0.005, ***≤ 0.005, NS = not significant. For IL-1-treated cells, mRNA levels are normalized to vehicle control for each cell line.

Article Snippet: MDA-PCa-2b cells were maintained in HPC1/20% FB Essence (FBE) containing 0.5 ng/ml IL-1α (Gold Bio, St. Louis, MO; 1110–01A-10) or IL-1β (Gold Bio, St. Louis, MO; 1110–01B-10) for approximately 4 months; and the proliferative colonies that emerged were expanded and termed MDA-PCa-2b IL-1α subline (MDA-αs) and MDA-PCa-2b IL-1β subline (MDA-βs).

Techniques: Quantitative RT-PCR

Experimental protocols illustrating the times and routes of antiserum and drug adminstration. i.c.v.=intracerebroventicularly; i.p.=intraperitoneally; s.c. subcutaneously. pAb=anti-annexin 1 polyclonal antiserum (3 μl rat−1 i.c.v. or 1 ml kg−1, s.c); NSS=non-immune sheep serum (3 μl rat−1, i.c.v. or 1 ml kg−1, s.c); Cort=corticosterone (500 μg kg−1, i.p. in a volume of 1 ml kg−1); IL-1β=interleukin 1β (10 ng rat−1 in a volume of 3 μl, i.c.v. or 500 μg kg−1, i.p. in a volume of 1 ml kg−1); ANX-1=annexin 1Ac2 – 26 (0.1 – 10 ng rat−1 in a volume of 3 μl, i.c.v.). Corresponding volumes of saline (Sal) or vehicle (Veh) were administered as controls where appropriate.

Journal:

Article Title: Opposing influences of glucocorticoids and interleukin-1? on the secretion of growth hormone and ACTH in the rat in vivo : role of hypothalamic annexin 1

doi: 10.1038/sj.bjp.0704324

Figure Lengend Snippet: Experimental protocols illustrating the times and routes of antiserum and drug adminstration. i.c.v.=intracerebroventicularly; i.p.=intraperitoneally; s.c. subcutaneously. pAb=anti-annexin 1 polyclonal antiserum (3 μl rat−1 i.c.v. or 1 ml kg−1, s.c); NSS=non-immune sheep serum (3 μl rat−1, i.c.v. or 1 ml kg−1, s.c); Cort=corticosterone (500 μg kg−1, i.p. in a volume of 1 ml kg−1); IL-1β=interleukin 1β (10 ng rat−1 in a volume of 3 μl, i.c.v. or 500 μg kg−1, i.p. in a volume of 1 ml kg−1); ANX-1=annexin 1Ac2 – 26 (0.1 – 10 ng rat−1 in a volume of 3 μl, i.c.v.). Corresponding volumes of saline (Sal) or vehicle (Veh) were administered as controls where appropriate.

Article Snippet: Rat recombinant interleukin 1β (IL-1β), generously donated by Dr Mauro Perretti (William Harvey Research Institute, London) or purchased from ICN Pharmaceuticals Ltd (Basingstoke, Hants, U.K.) and corticosterone-21-acetate (Sigma) were each dissolved and diluted in sterile saline immediately before use.

Techniques: Saline

Effects of corticosterone (Cort, 500 μg kg−1, i.p.) and/or rat interleukin 1β (IL-1β, 10 ng rat−1, i.c.v.) on the plasma ACTH (a), serum GH (b) and serum LH (c) concentrations in rats pretreated 15 min before the steroid injection with anti-annexin 1 pAb (3 μl rat−1, i.c.v.) or an equal volume of non-immune sheep serum (NSS, i.c.v.). Values represent the mean±s.e.mean (n=6 – 7). **P<0.01 vs corresponding Sal-Sal control; ††P<0.01 vs Sal- IL-1β-treated group; ##P<0.01 vs Cort-Sal-treated group; N.S.=not significant (P>0.05), (ANOVA plus Scheffé's test).

Journal:

Article Title: Opposing influences of glucocorticoids and interleukin-1? on the secretion of growth hormone and ACTH in the rat in vivo : role of hypothalamic annexin 1

doi: 10.1038/sj.bjp.0704324

Figure Lengend Snippet: Effects of corticosterone (Cort, 500 μg kg−1, i.p.) and/or rat interleukin 1β (IL-1β, 10 ng rat−1, i.c.v.) on the plasma ACTH (a), serum GH (b) and serum LH (c) concentrations in rats pretreated 15 min before the steroid injection with anti-annexin 1 pAb (3 μl rat−1, i.c.v.) or an equal volume of non-immune sheep serum (NSS, i.c.v.). Values represent the mean±s.e.mean (n=6 – 7). **P<0.01 vs corresponding Sal-Sal control; ††P<0.01 vs Sal- IL-1β-treated group; ##P<0.01 vs Cort-Sal-treated group; N.S.=not significant (P>0.05), (ANOVA plus Scheffé's test).

Article Snippet: Rat recombinant interleukin 1β (IL-1β), generously donated by Dr Mauro Perretti (William Harvey Research Institute, London) or purchased from ICN Pharmaceuticals Ltd (Basingstoke, Hants, U.K.) and corticosterone-21-acetate (Sigma) were each dissolved and diluted in sterile saline immediately before use.

Techniques: Clinical Proteomics, Injection, Control

Effects of corticosterone (Cort, 500 μg kg−1, i.p.) and/or interleukin 1β (IL-1β, 10 ng rat−1, i.c.v.) on the plasma ACTH (a), serum GH (b) and serum LH (c) concentrations in rats pretreated 24 h before the steroid injection with anti-annexin 1 pAb (1 ml kg−1, s.c.) or an equal volume of non-immune sheep serum (NSS, s.c.). Sal=saline. Values represent the mean±s.e.mean (n=6 – 7). **P<0.01 vs Sal-Sal-treated control; ††P<0.01 vs Sal-IL-1β-treated group; #P<0.05, ##P<0.01 vs Cort-Sal-treated group; N.S.=not significant (P>0.05), (ANOVA plus Scheffé's test).

Journal:

Article Title: Opposing influences of glucocorticoids and interleukin-1? on the secretion of growth hormone and ACTH in the rat in vivo : role of hypothalamic annexin 1

doi: 10.1038/sj.bjp.0704324

Figure Lengend Snippet: Effects of corticosterone (Cort, 500 μg kg−1, i.p.) and/or interleukin 1β (IL-1β, 10 ng rat−1, i.c.v.) on the plasma ACTH (a), serum GH (b) and serum LH (c) concentrations in rats pretreated 24 h before the steroid injection with anti-annexin 1 pAb (1 ml kg−1, s.c.) or an equal volume of non-immune sheep serum (NSS, s.c.). Sal=saline. Values represent the mean±s.e.mean (n=6 – 7). **P<0.01 vs Sal-Sal-treated control; ††P<0.01 vs Sal-IL-1β-treated group; #P<0.05, ##P<0.01 vs Cort-Sal-treated group; N.S.=not significant (P>0.05), (ANOVA plus Scheffé's test).

Article Snippet: Rat recombinant interleukin 1β (IL-1β), generously donated by Dr Mauro Perretti (William Harvey Research Institute, London) or purchased from ICN Pharmaceuticals Ltd (Basingstoke, Hants, U.K.) and corticosterone-21-acetate (Sigma) were each dissolved and diluted in sterile saline immediately before use.

Techniques: Clinical Proteomics, Injection, Saline, Control

Effects of corticosterone (Cort, 500 μg kg−1, i.p.) and/or interleukin 1β (IL-1β, 500 μg kg−1, i.p.) on the plasma ACTH (a), serum GH (b) and serum LH (c) concentrations in rats pretreated 15 min before the steroid injection with anti-annexin 1 pAb (3 μl rat−1, i.c.v.) or an equal volume of non-immune sheep serum (NSS, i.c.v.). Sal=saline. Values represent the mean±s.e.mean (n=6 – 7). **P<0.01 vs Sal-Sal-treated control. ††P<0.01, vs corresponding Sal-IL-1β-treated group; N.S.=not significant (P>0.05), (ANOVA plus Scheffé's test).

Journal:

Article Title: Opposing influences of glucocorticoids and interleukin-1? on the secretion of growth hormone and ACTH in the rat in vivo : role of hypothalamic annexin 1

doi: 10.1038/sj.bjp.0704324

Figure Lengend Snippet: Effects of corticosterone (Cort, 500 μg kg−1, i.p.) and/or interleukin 1β (IL-1β, 500 μg kg−1, i.p.) on the plasma ACTH (a), serum GH (b) and serum LH (c) concentrations in rats pretreated 15 min before the steroid injection with anti-annexin 1 pAb (3 μl rat−1, i.c.v.) or an equal volume of non-immune sheep serum (NSS, i.c.v.). Sal=saline. Values represent the mean±s.e.mean (n=6 – 7). **P<0.01 vs Sal-Sal-treated control. ††P<0.01, vs corresponding Sal-IL-1β-treated group; N.S.=not significant (P>0.05), (ANOVA plus Scheffé's test).

Article Snippet: Rat recombinant interleukin 1β (IL-1β), generously donated by Dr Mauro Perretti (William Harvey Research Institute, London) or purchased from ICN Pharmaceuticals Ltd (Basingstoke, Hants, U.K.) and corticosterone-21-acetate (Sigma) were each dissolved and diluted in sterile saline immediately before use.

Techniques: Clinical Proteomics, Injection, Saline, Control

Comparison of the effects of treatment with corticosterone (Cort, 500 μg kg−1, i.p.) and annexin 1Ac2 – 26 (0.1 – 10 ng rat−1, i.c.v.) on the resting plasma ACTH (a), serum GH (b) and serum LH (c) concentrations in rats and on the responses to IL-1β (10 ng rat−1, i.c.v.). Values represent the mean±s.e.mean (n=6). *P<0.05, **P<0.01 vs annexin 1 vehicle alone (Veh, 3 μl rat−1). ††P<0.01 vs IL-1β alone (ANOVA plus Duncan's test).

Journal:

Article Title: Opposing influences of glucocorticoids and interleukin-1? on the secretion of growth hormone and ACTH in the rat in vivo : role of hypothalamic annexin 1

doi: 10.1038/sj.bjp.0704324

Figure Lengend Snippet: Comparison of the effects of treatment with corticosterone (Cort, 500 μg kg−1, i.p.) and annexin 1Ac2 – 26 (0.1 – 10 ng rat−1, i.c.v.) on the resting plasma ACTH (a), serum GH (b) and serum LH (c) concentrations in rats and on the responses to IL-1β (10 ng rat−1, i.c.v.). Values represent the mean±s.e.mean (n=6). *P<0.05, **P<0.01 vs annexin 1 vehicle alone (Veh, 3 μl rat−1). ††P<0.01 vs IL-1β alone (ANOVA plus Duncan's test).

Article Snippet: Rat recombinant interleukin 1β (IL-1β), generously donated by Dr Mauro Perretti (William Harvey Research Institute, London) or purchased from ICN Pharmaceuticals Ltd (Basingstoke, Hants, U.K.) and corticosterone-21-acetate (Sigma) were each dissolved and diluted in sterile saline immediately before use.

Techniques: Comparison, Clinical Proteomics